InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,425.20
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.27
(
-0.40%
)
Bitcoin
64,006.67
(
-0.41%
)
Post# of 253213
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 260
Posts 18197
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: None

Thursday, 06/21/2018 5:06:03 PM

Thursday, June 21, 2018 5:06:03 PM

Post# of 253213
UTSW/Merck open label, Phase 2 clinical trial involving Keytruda:

https://www.clinicaltrials.gov/ct2/show/NCT03519997?term=Pembrolizumab%2C+Bavituximab&rank=1

Above is new, previously unknown to me, one of 3 bavituximab trials listed on privately-held Oncologie web site for various oncology indications.

https://www.oncologie.international/ongoing-trials/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up